UBE2T and neoplasm: Most studies have focused on mutations in or overexpression of numerous E3 ubiquitin ligases that result in tumor suppression [15–17], while few have examined the effects of ubiquitin-conjugating enzymes (E2 enzymes) such as UBE2T.